Abstract
The binding of amyloid beta peptides (Aβ) to plasma membranes appears to be a promising point of intervention in the events leading to the development of Alzheimers disease (AD). This binding has been studied as regards the direct toxicity of Aβ on neurons, and the activation of a local inflammation phase involving microglia. By virtue of its structure, Aβ is able to bind to a variety of biomolecules, including lipids, proteoglycans and proteins. This review focuses on the membrane proteins that can mediate the interaction between Aβ and the plasma membranes in AD. On neurons, these are APP (amyloid precursor protein), the NMDA-R (Nmethyl- D-aspartate receptor), integrins, the β7nicotinic acetylcholine receptor (α7nAChR), the P75 neurotrophin receptor (P75NTR) and the CLAC-P / collagen type XXV (collagen-like Alzheimer amyloid plaque component precursor / collagen XXV). On glial cells, FPRL1 (formyl peptide receptor-like 1), the scavenger receptors A, BI (SR-A, SR-BI) and CD36, a complex involving CD36, α6β1-integrin and CD47, and heparan sulfate proteoglycans have been reported to bind Aβ. It should be noted that integrins, RAGE (receptor for advanced glycosylation endproducts), the Serpin-enzyme complex receptor (SEC-R) and the insulin receptor can bind Aβ and are present on neurons and on glial cells. After a presentation of the structure and the function of each of these proteins, the method used to prove their binding to Aβ is described, and the implication of this binding in AD is discussed. Finally, it is underlined that multireceptor complexes containing integrins may be involved in this interaction.
Keywords: Amyloid-beta, Alzheimer disease, membrane proteins, APP, NMDA receptor, a7nicotinic, acetylcholine receptor, scavenger receptors, integrins
Current Protein & Peptide Science
Title: Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease
Volume: 5 Issue: 1
Author(s): Yann Verdier and Botond Penke
Affiliation:
Keywords: Amyloid-beta, Alzheimer disease, membrane proteins, APP, NMDA receptor, a7nicotinic, acetylcholine receptor, scavenger receptors, integrins
Abstract: The binding of amyloid beta peptides (Aβ) to plasma membranes appears to be a promising point of intervention in the events leading to the development of Alzheimers disease (AD). This binding has been studied as regards the direct toxicity of Aβ on neurons, and the activation of a local inflammation phase involving microglia. By virtue of its structure, Aβ is able to bind to a variety of biomolecules, including lipids, proteoglycans and proteins. This review focuses on the membrane proteins that can mediate the interaction between Aβ and the plasma membranes in AD. On neurons, these are APP (amyloid precursor protein), the NMDA-R (Nmethyl- D-aspartate receptor), integrins, the β7nicotinic acetylcholine receptor (α7nAChR), the P75 neurotrophin receptor (P75NTR) and the CLAC-P / collagen type XXV (collagen-like Alzheimer amyloid plaque component precursor / collagen XXV). On glial cells, FPRL1 (formyl peptide receptor-like 1), the scavenger receptors A, BI (SR-A, SR-BI) and CD36, a complex involving CD36, α6β1-integrin and CD47, and heparan sulfate proteoglycans have been reported to bind Aβ. It should be noted that integrins, RAGE (receptor for advanced glycosylation endproducts), the Serpin-enzyme complex receptor (SEC-R) and the insulin receptor can bind Aβ and are present on neurons and on glial cells. After a presentation of the structure and the function of each of these proteins, the method used to prove their binding to Aβ is described, and the implication of this binding in AD is discussed. Finally, it is underlined that multireceptor complexes containing integrins may be involved in this interaction.
Export Options
About this article
Cite this article as:
Verdier Yann and Penke Botond, Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease, Current Protein & Peptide Science 2004; 5 (1) . https://dx.doi.org/10.2174/1389203043486937
DOI https://dx.doi.org/10.2174/1389203043486937 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
Current Cancer Drug Targets The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy
Current Topics in Medicinal Chemistry Anticancer and Antimicrobial Evaluations on Alternative Reading Frame (ARF) Peptides and their Derivatives
Protein & Peptide Letters Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Current Cancer Drug Targets Anticancer Mechanisms of Bioactive Peptides
Protein & Peptide Letters Tamarix articulata (T. articulata) - An Important Halophytic Medicinal Plant with Potential Pharmacological Properties
Current Pharmaceutical Biotechnology Medicinal Value and Potential Therapeutic Mechanisms of Gynostemma pentaphyllum (Thunb.) Makino and Its Derivatives: An Overview
Current Topics in Medicinal Chemistry Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Current Neuropharmacology Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer
Combinatorial Chemistry & High Throughput Screening The Role of Traditional Chinese Herbal Medicines and Bioactive Ingredients on Ion Channels: A Brief Review and Prospect
CNS & Neurological Disorders - Drug Targets Down with the Erythropoietin. Long Live the Erythropoietin !
Current Drug Targets The Therapeutic Potential of Rutin for Diabetes: An Update
Mini-Reviews in Medicinal Chemistry Antiproliferative and Proapoptotic Effects of the TrK-inhibitor GW441756 in Human Myosarcomas and Prostatic Carcinoma
Current Signal Transduction Therapy Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential
Current Pharmaceutical Design Interleukin-18: Biology and Role in the Immunotherapy of Cancer
Current Medicinal Chemistry Anti-Tumor Monoclonal Antibodies in Conjunction with β-Glucans: A Novel Anti- Cancer Immunotherapy
Current Medicinal Chemistry Hedgehog Signaling and Urological Cancers
Current Drug Targets Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders
Current Protein & Peptide Science Sulfation of Phenylephrine by the Human Cytosolic Sulfotransferases
Drug Metabolism Letters Mitochondrial Superoxide Dismutase: A Promising Target for New Anticancer Therapies
Current Medicinal Chemistry